Patent directory · USPTO A61K / A61P
Patents matching “administration”
271 pharma patents match "administration" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 271 pharmaceutical patents matching "administration" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
CA 3203431
PROCEDES D'AMELIORATION DE RENDEMENT MUSCULAIRE OU DE REDUCTION DE FATIGUE CHRONIQUE PAR ADMINISTRATION D'EXOSOMES DERIVES DU LAIT BOVIN
granted -
US 11364260
Methods and compositions for administration of iron
granted -
US 11357782
Treprostinil administration by inhalation
granted -
US 11344568
Methods and compositions for administration of iron
granted -
US 11318211
Dosage regimes for the administration of an anti-CD19 ADC
granted -
US 11285145
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
granted -
US 11266724
Modified factor VII polypeptides for subcutaneous administration and on-demand treatment
granted -
US 11253494
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted -
US 11234971
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
granted -
US 11213524
Pharmaceutical compositions for subcutaneous administration of levosimendan
granted -
US 11185575
Subcutaneous administration of ADAMTS13
granted -
US 11168142
Administration of kynurenine depleting enzymes for tumor therapy
granted -
US 2021338651
METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS
granted -
US 11147770
Pharmaceutical composition and administrations thereof
granted -
US 11135283
Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
granted -
US 11084865
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 11066458
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 11052075
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
granted -
SG 11202104918P
THERAPY FOR TREATING CANCER WITH AN INTRATUMORAL AND/OR INTRAVENOUS ADMINISTRATION OF A RECOMBINANT MVA ENCODING 4-1BBL (CD137L) AND/OR CD40L
granted -
US 11040029
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11033587
Administration of cells and cellular extracts for rejuvenation
granted -
US 11033611
Compositions and methods for administration of an enzyme to a subject's airway
granted -
US 11026931
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11020373
Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
granted